Global Obesity Treating Neuromodulation System Market Insights, Forecast to 2025

Publisher Name :
Date: 10-May-2019
No. of pages: 116
Inquire Before Buying

Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.

North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.

The global Obesity Treating Neuromodulation System market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Obesity Treating Neuromodulation System market based on company, product type, end user and key regions.

This report studies the global market size of Obesity Treating Neuromodulation System in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Obesity Treating Neuromodulation System in these regions.

This research report categorizes the global Obesity Treating Neuromodulation System market by top players/brands, region, type and end user. This report also studies the global Obesity Treating Neuromodulation System market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Medtronic

- Cyberonics

- St. Jude Medical

- BioControl Medical

- Leptos Medical

- EnteroMedics

- Nevro

- Nuvectra

Market size by Product

- Vagus Nerve Stimulator

- Splanchnic Nerve Stimulator

- Deep Brain Stimulator

- Spinal Cord Stimulator

- Autonomous Nerve Stimulator

- Others

Market size by End User

- Hospitals

- Clinics

- Ambulatory Surgical Centers

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Obesity Treating Neuromodulation System market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Obesity Treating Neuromodulation System market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Obesity Treating Neuromodulation System companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Obesity Treating Neuromodulation System submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Obesity Treating Neuromodulation System are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Obesity Treating Neuromodulation System market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Obesity Treating Neuromodulation System Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Obesity Treating Neuromodulation System Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by Product
1.4.2 Vagus Nerve Stimulator
1.4.3 Splanchnic Nerve Stimulator
1.4.4 Deep Brain Stimulator
1.4.5 Spinal Cord Stimulator
1.4.6 Autonomous Nerve Stimulator
1.4.7 Others
1.5 Market by End User
1.5.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Obesity Treating Neuromodulation System Market Size
2.1.1 Global Obesity Treating Neuromodulation System Revenue 2014-2025
2.1.2 Global Obesity Treating Neuromodulation System Sales 2014-2025
2.2 Obesity Treating Neuromodulation System Growth Rate by Regions
2.2.1 Global Obesity Treating Neuromodulation System Sales by Regions
2.2.2 Global Obesity Treating Neuromodulation System Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Obesity Treating Neuromodulation System Sales by Manufacturers
3.1.1 Obesity Treating Neuromodulation System Sales by Manufacturers
3.1.2 Obesity Treating Neuromodulation System Sales Market Share by Manufacturers
3.1.3 Global Obesity Treating Neuromodulation System Market Concentration Ratio (CR5 and HHI)
3.2 Obesity Treating Neuromodulation System Revenue by Manufacturers
3.2.1 Obesity Treating Neuromodulation System Revenue by Manufacturers (2014-2019)
3.2.2 Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2014-2019)
3.3 Obesity Treating Neuromodulation System Price by Manufacturers
3.4 Obesity Treating Neuromodulation System Manufacturing Base Distribution, Product Types
3.4.1 Obesity Treating Neuromodulation System Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Obesity Treating Neuromodulation System Product Type
3.4.3 Date of International Manufacturers Enter into Obesity Treating Neuromodulation System Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Obesity Treating Neuromodulation System Sales by Product
4.2 Global Obesity Treating Neuromodulation System Revenue by Product
4.3 Obesity Treating Neuromodulation System Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Obesity Treating Neuromodulation System Breakdown Data by End User
6 North America
6.1 North America Obesity Treating Neuromodulation System by Countries
6.1.1 North America Obesity Treating Neuromodulation System Sales by Countries
6.1.2 North America Obesity Treating Neuromodulation System Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Obesity Treating Neuromodulation System by Product
6.3 North America Obesity Treating Neuromodulation System by End User
7 Europe
7.1 Europe Obesity Treating Neuromodulation System by Countries
7.1.1 Europe Obesity Treating Neuromodulation System Sales by Countries
7.1.2 Europe Obesity Treating Neuromodulation System Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Obesity Treating Neuromodulation System by Product
7.3 Europe Obesity Treating Neuromodulation System by End User
8 Asia Pacific
8.1 Asia Pacific Obesity Treating Neuromodulation System by Countries
8.1.1 Asia Pacific Obesity Treating Neuromodulation System Sales by Countries
8.1.2 Asia Pacific Obesity Treating Neuromodulation System Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Obesity Treating Neuromodulation System by Product
8.3 Asia Pacific Obesity Treating Neuromodulation System by End User
9 Central & South America
9.1 Central & South America Obesity Treating Neuromodulation System by Countries
9.1.1 Central & South America Obesity Treating Neuromodulation System Sales by Countries
9.1.2 Central & South America Obesity Treating Neuromodulation System Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Obesity Treating Neuromodulation System by Product
9.3 Central & South America Obesity Treating Neuromodulation System by End User
10 Middle East and Africa
10.1 Middle East and Africa Obesity Treating Neuromodulation System by Countries
10.1.1 Middle East and Africa Obesity Treating Neuromodulation System Sales by Countries
10.1.2 Middle East and Africa Obesity Treating Neuromodulation System Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Obesity Treating Neuromodulation System by Product
10.3 Middle East and Africa Obesity Treating Neuromodulation System by End User
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Company Business Overview
11.1.3 Medtronic Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Medtronic Obesity Treating Neuromodulation System Products Offered
11.1.5 Medtronic Recent Development
11.2 Cyberonics
11.2.1 Cyberonics Company Details
11.2.2 Company Business Overview
11.2.3 Cyberonics Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Cyberonics Obesity Treating Neuromodulation System Products Offered
11.2.5 Cyberonics Recent Development
11.3 St. Jude Medical
11.3.1 St. Jude Medical Company Details
11.3.2 Company Business Overview
11.3.3 St. Jude Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.3.4 St. Jude Medical Obesity Treating Neuromodulation System Products Offered
11.3.5 St. Jude Medical Recent Development
11.4 BioControl Medical
11.4.1 BioControl Medical Company Details
11.4.2 Company Business Overview
11.4.3 BioControl Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BioControl Medical Obesity Treating Neuromodulation System Products Offered
11.4.5 BioControl Medical Recent Development
11.5 Leptos Medical
11.5.1 Leptos Medical Company Details
11.5.2 Company Business Overview
11.5.3 Leptos Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Leptos Medical Obesity Treating Neuromodulation System Products Offered
11.5.5 Leptos Medical Recent Development
11.6 EnteroMedics
11.6.1 EnteroMedics Company Details
11.6.2 Company Business Overview
11.6.3 EnteroMedics Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.6.4 EnteroMedics Obesity Treating Neuromodulation System Products Offered
11.6.5 EnteroMedics Recent Development
11.7 Nevro
11.7.1 Nevro Company Details
11.7.2 Company Business Overview
11.7.3 Nevro Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Nevro Obesity Treating Neuromodulation System Products Offered
11.7.5 Nevro Recent Development
11.8 Nuvectra
11.8.1 Nuvectra Company Details
11.8.2 Company Business Overview
11.8.3 Nuvectra Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Nuvectra Obesity Treating Neuromodulation System Products Offered
11.8.5 Nuvectra Recent Development
12 Future Forecast
12.1 Obesity Treating Neuromodulation System Market Forecast by Regions
12.1.1 Global Obesity Treating Neuromodulation System Sales Forecast by Regions 2019-2025
12.1.2 Global Obesity Treating Neuromodulation System Revenue Forecast by Regions 2019-2025
12.2 Obesity Treating Neuromodulation System Market Forecast by Product
12.2.1 Global Obesity Treating Neuromodulation System Sales Forecast by Product 2019-2025
12.2.2 Global Obesity Treating Neuromodulation System Revenue Forecast by Product 2019-2025
12.3 Obesity Treating Neuromodulation System Market Forecast by End User
12.4 North America Obesity Treating Neuromodulation System Forecast
12.5 Europe Obesity Treating Neuromodulation System Forecast
12.6 Asia Pacific Obesity Treating Neuromodulation System Forecast
12.7 Central & South America Obesity Treating Neuromodulation System Forecast
12.8 Middle East and Africa Obesity Treating Neuromodulation System Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Obesity Treating Neuromodulation System Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Obesity Treating Neuromodulation System Product Picture
Table Obesity Treating Neuromodulation System Market Segments
Table Key Manufacturers Obesity Treating Neuromodulation System Covered
Table Global Obesity Treating Neuromodulation System Market Size Growth Rate by Product 2019-2025 (Units) & (Million US$)
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Product 2014-2025
Figure Vagus Nerve Stimulator Product Picture
Table Major Manufacturers of Vagus Nerve Stimulator
Figure Splanchnic Nerve Stimulator Product Picture
Table Major Manufacturers of Splanchnic Nerve Stimulator
Figure Deep Brain Stimulator Product Picture
Table Major Manufacturers of Deep Brain Stimulator
Figure Spinal Cord Stimulator Product Picture
Table Major Manufacturers of Spinal Cord Stimulator
Figure Autonomous Nerve Stimulator Product Picture
Table Major Manufacturers of Autonomous Nerve Stimulator
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Obesity Treating Neuromodulation System Market Size Growth Rate by End User 2019-2025 (Units)
Figure Hospitals
Figure Clinics
Figure Ambulatory Surgical Centers
Figure Obesity Treating Neuromodulation System Report Years Considered
Figure Global Obesity Treating Neuromodulation System Market Size 2014-2025 (Million US$)
Figure Global Obesity Treating Neuromodulation System Sales 2014-2025 (Units)
Table Global Obesity Treating Neuromodulation System Market Size by Regions 2014-2019 (Units) & (Million US$)
Table Global Obesity Treating Neuromodulation System Sales by Regions 2014-2019 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share by Regions 2014-2019
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Regions 2014-2019
Figure 2018 Global Obesity Treating Neuromodulation System Sales Market Share by Regions
Table Global Obesity Treating Neuromodulation System Revenue by Regions 2014-2019 (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Market Share by Regions 2014-2019
Figure Global Obesity Treating Neuromodulation System Revenue Market Share by Regions 2014-2019
Figure 2018 Global Obesity Treating Neuromodulation System Revenue Market Share by Regions
Table Global Obesity Treating Neuromodulation System Sales by Manufacturers (2014-2019) (Units)
Table Global Obesity Treating Neuromodulation System Sales Share by Manufacturers (2014-2019)
Figure Global Obesity Treating Neuromodulation System Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Obesity Treating Neuromodulation System Revenue by Manufacturers (2014-2019) (Million USD)
Table Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2014-2019)
Figure Obesity Treating Neuromodulation System Value Share by Manufacturers in 2018
Table Key Manufacturers Obesity Treating Neuromodulation System Price (2014-2019) (USD/Unit)
Table Obesity Treating Neuromodulation System Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Obesity Treating Neuromodulation System Product Type
Table Date of International Manufacturers Enter into Obesity Treating Neuromodulation System Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Global Obesity Treating Neuromodulation System Sales Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Product in 2018
Table Global Obesity Treating Neuromodulation System Revenue by Product (2014-2019) (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Revenue Market Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Revenue Market Share by Product in 2018
Table Obesity Treating Neuromodulation System Price by Product 2014-2019 (USD/Unit)
Table Global Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Global Obesity Treating Neuromodulation System Sales Share by End User (2014-2019)
Figure Global Sales Obesity Treating Neuromodulation System Market Share by End User (2014-2019)
Figure Global Sales Obesity Treating Neuromodulation System Market Share by End User in 2018
Figure North America Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure North America Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table North America Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table North America Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Sales Market Share by Countries
Table North America Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table North America Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure United States Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure United States Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Units)
Figure Canada Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Canada Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Mexico Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table North America Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table North America Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Market Share by Product
Table North America Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table North America Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Market Share by End User
Figure Europe Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Europe Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Europe Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Europe Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Europe Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure Germany Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Germany Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure France Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure France Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure UK Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Italy Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Russia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Europe Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Market Share by Product
Table Europe Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Europe Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Market Share by End User
Figure Asia Pacific Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Asia Pacific Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Asia Pacific Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure China Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure China Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Japan Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Korea Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure India Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure India Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Australia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Indonesia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Malaysia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Philippines Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Thailand Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Vietnam Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Singapore Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Market Share by Product
Table Asia Pacific Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Market Share by End User
Figure Central & South America Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Central & South America Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Central & South America Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Central & South America Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure Brazil Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Brazil Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Argentina Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Central & South America Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Market Share by Product
Table Central & South America Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Central & South America Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Market Share by End User
Figure Middle East and Africa Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Middle East and Africa Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Middle East and Africa Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure GCC Countries Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure GCC Countries Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Turkey Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Egypt Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure South Africa Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Market Share by Product
Table Middle East and Africa Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Market Share by End User
Table Medtronic Company Details
Table Medtronic Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medtronic Recent Development
Table Cyberonics Company Details
Table Cyberonics Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cyberonics Recent Development
Table St. Jude Medical Company Details
Table St. Jude Medical Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table St. Jude Medical Recent Development
Table BioControl Medical Company Details
Table BioControl Medical Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioControl Medical Recent Development
Table Leptos Medical Company Details
Table Leptos Medical Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Leptos Medical Recent Development
Table EnteroMedics Company Details
Table EnteroMedics Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table EnteroMedics Recent Development
Table Nevro Company Details
Table Nevro Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nevro Recent Development
Table Nuvectra Company Details
Table Nuvectra Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nuvectra Recent Development
Table Global Obesity Treating Neuromodulation System Sales Forecast by Regions 2019-2025 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share Forecast by Regions 2019-2025
Table Global Obesity Treating Neuromodulation System Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Market Share Forecast by Regions 2019-2025
Table Global Obesity Treating Neuromodulation System Sales Forecast by Product 2019-2025 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share Forecast by Product 2019-2025
Table Global Obesity Treating Neuromodulation System Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Market Share Forecast by Product 2019-2025
Table Global Obesity Treating Neuromodulation System Sales Forecast by End User 2019-2025 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share Forecast by End User 2019-2025
Figure North America Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure North America Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Europe Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Asia Pacific Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Central & South America Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Middle East and Africa Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Obesity Treating Neuromodulation System Value Chain
Table Obesity Treating Neuromodulation System Customers List
Table Obesity Treating Neuromodulation System Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs